AI Terminal

MODULE: AI_ANALYST
Interactive Q&A, Risk Assessment, Summarization
MODULE: DATA_EXTRACT
Excel Export, XBRL Parsing, Table Digitization
MODULE: PEER_COMP
Sector Benchmarking, Sentiment Analysis
SYSTEM ACCESS LOCKED
Authenticate / Register Log In

Melexis N.V.

Earnings Release Apr 29, 2020

3975_10-q_2020-04-29_c9f228df-60f4-4357-ba4d-e293e3fb069a.pdf

Earnings Release

Open in Viewer

Opens in native device viewer

Press release - Regulated Information

Melexis Q1 2020 results – First quarter sales of 138.2 million EUR

Intermediate declaration by the Board of Directors

Ieper, Belgium – April 29th, 2020, 07.00 hrs CET

CONFORM IFRS Q1 2020 Q1 2019 YOY growth Q4 2019 SEQ growth
in k EUR (%) (%)
Sales 138,162 116,511 19% 127,052 9%
Gross result 56,033 46,755 20% 50,424 11%
Gross Margin 40.6% 40.1% 39.7%
EBIT 23,980 15,739 52% 18,280 31%
EBIT in % 17.4% 13.5% 14.4%
EBITDA 36,112 27,932 29% 30,773 17%
EBITDA in % 26.1% 24.0% 24.2%
Net result 20,706 13,946 48% 15,371 35%
Net result per share (EPS) 0.51 0.35 0.38
CAPEX 6,783 6,987 6,081

Sales for the first quarter of 2020 were 138.2 million EUR, an increase of 19% compared to the same quarter of the previous year and an increase of 9% compared to the previous quarter.

The EUR/USD exchange rate evolution had a positive impact on sales of 1% compared to the same quarter of last year and no impact compared to the previous quarter.

The gross result was 56.0 million EUR or 40.6% of sales, an increase of 20% compared to the same quarter of last year and an increase of 11% compared to the previous quarter.

R&D expenses were 14.9% of sales, G&A was at 5.7% of sales and Selling was at 2.7% of sales. The operating result was 24.0 million EUR or 17.4% of sales, an increase of 52% compared to the same quarter of last year and an increase of 31% compared to the previous quarter.

The net result was 20.7 million EUR or 0.51 EUR per share, an increase of 48% compared to 13.9 million EUR or 0.35 EUR per share in the first quarter of 2019 and an increase of 35% compared to the previous quarter.

Outlook

Melexis reiterates its announcement of April 1st to withdraw its full year 2020 outlook, as the economic impact resulting from the COVID-19 pandemic cannot be quantified at this moment.

Business comment – Françoise Chombar, CEO:

"Melexis had a solid start of the year with a 19% year-over-year and a 9% sequential sales growth, which is at the high end of the sales guidance provided at the beginning of the year. Leaving aside the negative impact of COVID-19 at the end of March, sales were heading for more than 140 million EUR.

Melexis continues to serve customers in the best possible way, despite ongoing supply chain disruptions, mainly in chip assembly (packaging). On the demand side, many customers - mainly in Europe and the US have shut down due to COVID-19 lockdown measures, while mostly Asian customers have restarted operations. The combined impact of disruptions, both on the supply and the demand side, will have a significant negative impact on sales in the second quarter. A positive element, which we expect will soften the impact, is that inventory levels of Melexis' products at customer level are estimated to be low.

In the first quarter, the outperforming product lines were temperature sensors, pressure sensors, magnetic position sensors and embedded motor drivers.

As announced earlier, stronger demand in temperature sensors is linked to the fact that our products are critical components to much of the equipment to overcome the COVID-19 pandemic, ranging from diagnostics, over fever measurement and respiratory devices.

In the automotive industry, the China 6 norm benefits our pressure sensors in multiple ways, for example in the area of gasoline particulate filters.

New magnetic position sensor content growth comes from the chassis, transmission, and braking areas thanks to x-by-wire operation, additional controls and higher functional safety and reliability. Autonomous driving and electrified powertrains, for example, create new challenges that our 3rd generation Triaxis® sensors are able to meet with their high functional safety level and stray field robust mode.

We observe an increasing trend, both for new energy and for conventional fuel cars, towards small cooling pumps or sensored cooling valves for better thermal management, which is being served with our embedded motor drivers. Melexis has also been benefiting from more sales for air grille shutters which reduce fuel or battery energy consumption.

Sales to automotive customers represented 91% of total sales in the first quarter of 2020. The portion of standard product (ASSPs) sales represented 65% of total sales in the first quarter of 2020."

Financial Calendar

  • Annual Shareholders Meeting: May 12, 2020
  • Publication Q2 Results 2020: July 29, 2020 (at 7 hrs CET)
  • Publication Q3 Results 2020: October 28, 2020 (at 7 hrs CET)
  • Publication FY 2020 Results: February 3, 2021 (at 7 hrs CET)

The company's results will be discussed in a conference call on Wednesday, April 29th, 2020 at 10:30 hrs CET. The conference call will be in English. You have to register for this conference call in advance. You can register by clicking here and filling out the requested information.

After registration, you will receive the conference call number, a participant user pin, conference pin and instructions on how to join the conference call. For security purposes, all participants must register individually if they wish to join the call.

For more information: Investor Relations Phone: +32 13 67 07 79 Email: [email protected]

About Melexis

Combining a passion for technology with truly inspired engineering, Melexis designs, develops and delivers innovative micro-electronic solutions that enable designers to turn ideas into applications that support the best imaginable future. The company's advanced mixed-signal semiconductor sensor and actuator components address the challenges of integrating sensing, driving and communication into next-generation products and systems that improve safety, raise efficiency, support sustainability and enhance comfort. Melexis is headquartered in Belgium and employs over 1500 people in 19 locations worldwide. The company is publicly traded on Euronext Brussels (MELE). For more information, visit www.melexis.com

Disclaimer

Except for those statements that report the Company's historical results, the statements being made are forward looking statements. Actual results could differ materially from those projected in the forwardlooking statements. Factors which could cause actual results to differ from expectations include the following: volatility in supply and demand affecting revenues and market prices, price and availability of silicon foundry, assembly and test prices, assembly and test subcontract capacity required to meet financial targets and/or meet backlog requirements, risks and delays associated with bringing up new production capabilities or with deliveries from subcontractors, timing and market acceptance of new products, increased expenses associated with new product acceptance of new products, increased expenses associated with new product introductions of process changes, delays in developing or achieving volume production of new products, which can result in delays or failure to contribute to revenues and profits, ability of the Company to maintain its customer and vendor base and delays in and/or inability in raising additional capital.

Consolidated Income Statement

CONFORM IFRS Quarter ended
31/03/2020
Quarter ended
31/03/2019
Year ended
31/12/2019
in k EUR audited
Sales 138,162 116,511 486,862
Cost of sales -82,129 -69,756 -290,628
Gross result 56,033 46,755 196,234
R&D -20,519 -19,763 -79,558
G&A -7,815 -7,599 -30,600
Selling -3,719 -3,653 -15,450
Other operating result
Operating result (EBIT) 23,980 15,739 70,626
Financial result -449 -333 -1,378
Result before taxes 23,530 15,406 69,248
Income taxes -2,824 -1,460 -8,993
Net result 20,706 13,946 60,255
Net result per share in EUR 0.51 0.35 1.49

Consolidated Statement of Financial Position

CONFORM IFRS Quarter ended
31/03/2020
Quarter ended
31/03/2019
Year ended
31/12/2019
in k EUR audited
Current Assets :
Cash and cash equivalents 51,051 39,554 38,772
Current investments 2 0 78
A/R Trade 69,149 65,678 58,310
A/R from related parties 61 272 136
Advance related parties
Assets for current tax 1,848 1,243 1,745
Assets held for sale
Other current assets 12,833 11,701 9,781
Inventories 129,887 124,941 128,505
Total current assets 264,832 243,387 237,328
Non-current assets :
Costs of incorporation
Property, plant and equipment 140,711 154,699 143,608
Leased assets 4,489 5,177 4,813
Financial assets 0 0 0
Intangible fixed assets 4,765 4,926 5,209
A/R directors
Other non-current assets 3 8 3
Deferred tax assets 28,057 24,477 27,649
Total non current assets 178,025 189,288 181,282
Total assets 442,857 432,675 418,610

CONFORM IFRS Quarter ended
31/03/2020
Quarter ended
31/03/2019
Year ended
31/12/2019
in k EUR audited
Liabilities and shareholders Equity
Current liabilities :
Bank loans and overdrafts
Derivative financial instruments 0 25 0
Current portion of LT debt 0 1,000 0
Lease liabilities 1,405 1,013 1,825
A/P trade 15,160 16,737 16,139
Affiliated companies 16,588 13,473 15,733
Accrued taxes 2,603 2,264 3,251
Accrued expenses and payroll 15,366 13,693 10,643
Other current liabilities 4,710 3,078 4,305
Deferred income 2,012 2,978 2,280
Total current liabilities 57,845 54,262 54,176
Non current liabilities :
LT debt less current portion 62,000 34,000 62,000
Lease liabilities 3,127 3,791 3,027
Deferred tax liabilities 327 280 337
Other non-current liabilities 0 0 0
Total non current liabilities 65,454 38,070 65,364
Shareholders' equity :
Shareholders' capital
Share premium
565 565 565
Treasury shares -3,818 -3,818 -3,818
Revaluation reserve Hedge 0 0 0
Revaluation reserve Fair value 0 0 0
Legal reserve 57 57 57
Retained earnings 306,856 334,719 246,601
Current period's profit 20,706 13,946 60,255
Cumulative translation adjustment -4,808 -5,137 -4,590
Equity attributable to company owners 319,557 340,332 299,070
Non controlling interests 0 10 0
Total shareholders equity 319,558 340,343 299,070
Total liabilities, shareholders' equity 442,857 432,675 418,610
and minority interests

Consolidated Statements of Cash Flow

CONFORM IFRS Quarter ended Quarter ended Year ended
31/03/2020 31/03/2019 31/12/2019
(in k EUR) audited
Cash flow from operating activities
Net income
Adjustments for :
20,706
0
13,946
0
60,255
Operating activities 14,887 14,418 59,459
Deferred taxes -408 517 -2,655
Capital grants 193 173 1,099
Depreciation and amortisation 11,654 11,780 46,760
Depreciation leased assets 479 413 1,845
Accrued income tax 2,590 356 10,374
Unrealized exchange results -3 -36 -604
Financial result 382 1,217 2,640
Operating profit before working capital changes 35,592 28,364 119,714
A/R, Trade -10,866 9,555 16,938
A/R, affiliates 74 -111 25
Other current assets -3,325 -3,214 -2,687
Other non current assets 0 -4 1
Inventories -2,913 -6,222 -14,303
A/P -955 -4,138 -4,678
A/P affiliates 856 -495 1,765
Accrued expenses 4,723 3,192 141
Other current liabilities 302 121 1,537
Other non current liabilities -278 -56 -721
Interest paid
Income tax paid
-124
-3,238
-120
-13,776
-523
-22,808
Cash flow from operating activities 19,850 13,097 94,400
0 0
0 0
Cash flow from investing activities 0 0
Acquisition of subsidiary, net of cash acquired 0 0
Financial fixed assets 0 0
Purchase of PPE and intangible assets (netted) -6,783 -6,987 -26,632
Interest received 31 0 90
Investments/proceeds/ from current investments 76 101 22
Investments/proceeds/ from non current investments 0 0
(incl. financial instruments) 0 0
Cash provided from investing activities -6,676 -6,886 -26,519
0 0
Cash flows from financing activities
Payment to acquire own shares
0
0
0
0
Proceeds/Repayment of long-and short-term debt -21 -82 26,927
Proceeds/Repayment of bank loans and overdrafts 0 0
Repayment leasings -475 -786 -1,805
Proceeds from (repayment of) related party financing 0 0
Impact of exchange results on financing items -349 -357 -661
Dividend payment 0 0 -88,118
Capital Decrease 0 0
Non controlling interests 0 0 -10
Cash provided from financing activities -845 -1,225 -63,668
0 0
CTA -49 46 37
Increase/decrease in cash and cash equivalents 12,279 5,032 4,250
Cash at beginning of the period 38,772 34,522 34,522
Cash at the end of the period 51,051 39,554 38,772

Sales per Geography

Q1 2020 Q1 2019 FY 2019
APAC
Asia Pacific
51% 44% 47%
EMEA
Europe - Middle-East - Africa
36% 42% 39%
NALA
North America - Latin America
13% 14% 14%
TOTAL 100% 100% 100%

Talk to a Data Expert

Have a question? We'll get back to you promptly.